Kinetic Properties of Hexokinase under Near-Physiological Conditions: Relation to Metabolic Arrest in Artemia Embryos During Anoxia by Rees, Bernard
University of New Orleans 
ScholarWorks@UNO 
Biological Sciences Faculty Publications Department of Biological Sciences 
9-1989 
Kinetic Properties of Hexokinase under Near-Physiological 
Conditions: Relation to Metabolic Arrest in Artemia Embryos 
During Anoxia 
Bernard Rees 
University of New Orleans, brees@uno.edu 
Follow this and additional works at: https://scholarworks.uno.edu/biosciences_facpubs 
 Part of the Biology Commons 
Recommended Citation 
Rees, B.B., Ropson, I.J., and Hand, S.C. 1989. Kinetic properties of hexokinase under near-physiological 
conditions: relation to metabolic arrest in Artemia embryos during anoxia. Journal of Biological Chemistry 
264 (26): 15410-15417. 
This Article is brought to you for free and open access by the Department of Biological Sciences at 
ScholarWorks@UNO. It has been accepted for inclusion in Biological Sciences Faculty Publications by an 
authorized administrator of ScholarWorks@UNO. For more information, please contact scholarworks@uno.edu. 
THE JOURNAL 
0 1989 by The American Society for  Biochemistry and Molecular 
OF BIOLOGICAL CHEMISTRY 
‘Biology, lnc 
Val. 264. , No. 26, Issue of September 15, pp. 15410-15417,1989 
Printed in U.S.A. 
Kinetic Properties of Hexokinase under Near-physiological Conditions 
RELATION TO METABOLIC ARREST IN ARTEMIA EMBRYOS DURING ANOXIA* 
(Received for publication, October 31, 1988) 
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Previous analyses of glycolytic metabolites in Ar- 
temia embryos  indicate  that  an  acute  inhibition of glu- 
cose phosphorylation  occurs during pHi-mediated met- 
abolic arrest  under anoxia. We describe here  kinetic 
features of hexokinase  purified  from brine  shrimp em- 
bryos  in  an  attempt to  explain  the molecular  basis for 
this  inhibition. At saturating  concentrations of cosub- 
strate, ADP is an uncompetitive  inhibitor toward glu- 
cose and a partial noncompetitive inhibitor toward 
ATP (Ki, = 0.86 mM, Kii = 1.0 mM, K i d  = 1.9 mM). With 
cosubstrates at  subsaturating  concentrations,  the  un- 
competitive  inhibition versus glucose becomes noncom- 
petitive,  while  inhibition versus ATP remains  partial 
noncompetitive. The  partial noncompetitive  inhibition 
of ADP versus ATP is characterized  by  a  hyperbolic 
intercept  replot.  These  product  inhibition  patterns are 
consistent  with a random mechanism of enzyme  action 
that follows the  preferred  order of glucose binding first 
and glucose-6-P  dissociating  last. We propose that  in- 
hibition by glucose-6-P (& = 65 PM) occurs  primarily 
by competing with ATP at  the active  site,  resulting  in 
the  formation of the dead-end complex, enzyme-glu- 
eose-glucose-6-P. Versus glucose, inhibition by glu- 
cose-6-P is uncompetitive at pH 8.0 and noncompeti- 
tive at pH 6.8. Over a physiologically relevant pH 
range of 8.0 to 6.8 alterations  in K ,  and Ki values  do 
not  account €or the  reduction  in glucose phosphoryla- 
tion,  and no evidence  suggests that Artemia hexoki- 
nase activity is modulated by reversible binding to 
intracellular structures. Total aluminum in the em- 
bryos is 4.01 f 0.36 pg)g dry weight,  or,  based upon 
tissue  hydration, 72 PM. This concentration of alumi- 
num  dramatically  reduces  enzyme  activity at pH values 
c 7.2, even  in the presence of physiological metal ion 
chelators (citrate, phosphate). When pH, aluminum, 
citrate, phosphate,  substrates,  and  products  were 
maintained at cellular  levels  measured  under  anoxia, 
we can account for a 90% inhibition of hexokinase 
relative  to  activity  under  control (aerobic) conditions. 
Hexokinase (EC 2.7.1.1) plays a major role  in the regulation 
of carbohydrate metabolism in mammalian cells that utilize 
glucose as a primary energy source. Glucose 6-phosphate,  a 
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product and  potent inhibitor of the hexokinase reaction, is 
presumed to be the primary regulator of activity (Colowick, 
1973), although  alterations  in the subcellular distribution of 
the enzyme are physiologically important depending on the 
tissue (Wilson, 1980; 1985). It is thought that a negative 
cross-over point in metabolite concentrations, indicative of 
enzyme inhibition, is typically not observed at  the hexokinase 
reaction because of product inhibition by glucose-6-P (Rolles- 
ton, 1972). However, this scenario is clearly not applicable to 
embryos of the brine shrimp, Artemia. Biochemical and ca- 
lorimetric studies have shown that  the predominantly treha- 
lose-based metabolism of the developing embryo is brought to 
a  virtual halt upon anaerobic incubation and is quickly rein- 
itiated upon return  to aerobic conditions (Ewing and Clegg, 
1969; Carpenter and Hand, 1986a; Hand  and Gnaiger, 1988). 
Analyses of glycolytic intermediates  in  these embryos during 
aerobic development and anaerobic dormancy have demon- 
strated  that trehalase, hexokinase and phosphofructokinase 
are  inhibited  under anaerobic conditions (Carpenter and 
Hand 1986a, 1986b; Hand  and Carpenter, 1986). Because the 
hexokinase inhibition occurs while cellular levels of glucose- 
6-P  are decreasing, other regulatory features in addition to 
product inhibition  must  be operative. In  the  present study,  a 
molecular and kinetic analysis was undertaken with hexoki- 
nase purified from post-diapause Artemia embryos to explain 
the inhibition of this enzyme that occurs in vivo during the 
transition between active and quiescence metabolic states. 
Recent observations indicate that alterations of intracellu- 
lar pH (pHi) may play a primary role in the regulation of 
carbohydrate metabolism in Artemia. pHi declines rapidly 
from values 27.9 during aerobic development to 6.0 during 
anaerobic incubation, eventually reaching pH 6.3 after several 
hours (Busa et al., 1982). Artificial acidification of pH,  to 6.8 
by elevated CO, (aerobic acidosis) results  in  a suppression of 
respiration rate (Busa and Crowe, 1983) and a blockage of 
carbohydrate metabolism characterized by cross-over points 
essentially identical to those  under anoxic conditions (Car- 
penter and Hand, 1986a). It is appropriate to note that while 
both the ATP:ADP ratio and adenylate energy charge sharply 
decline under anoxia, they remain constant under aerobic 
acidosis (Carpenter and Hand, 1986a). Thus, changes in aden- 
ylates are  not necessary for the observed hexokinase inhibi- 
tion. As a consequence, all  experiments in  the  present com- 
munication, including characterization of hexokinase reaction 
mechanism and studies of subcellular distribution and  inhi- 
bition  characteristics, were performed at  pH 8.0 and 6.8 in 
order to detect  any  pH-dependent changes in  these properties. 
Finally, Womack and Colowick (1979) reported that alu- 
minum ion at micromolar concentrations can inhibit hexoki- 
nase activity in  a  pH-dependent  manner. Until now, studies 
have not experimentally addressed the potential metabolic 
significance of this finding, but rather have viewed aluminum 
only as a common contaminant of ATP preparations. Consid- 
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ering  the  acute  pH  transition  that occurs during  entry  into 
anaerobic dormancy, we felt  it germane to  measure  the  alu- 
minum  content of Artemia embryos and  evaluate  the  inhibi- 
tion of hexokinase a t  physiological levels of this metal ion 
and  its major  cellular chelators. 
EXPERIMENTAL PROCEDURES’ 
In all cases, concentrations of the varied substrate bracketed the 
K ,  value, and assays were typically performed in duplicate. When 
values deviated by more than  lo%, quadruplicate  assays were done. 
The average standard error  within  a set of assays was 5.1% of the 
quadruplicate  mean.  Lineweaver-Burk  plots of initial velocity meas- 
urements were constructed for diagnostic purposes, but the lines 
given are those predicted by the appropriate rate equations. The 
nonlinear  least  squares regression procedure of the  Statistical Analy- 
sis  System (SAS Institute, Cary, NC) was used to determine  kinetic 
parameters, their  standard errors, and goodness of fit characteristics. 
The equations used to fit the various kinetic models were adopted 
from Segel(l975).  Equation 1 predicts enzyme velocity in a  sequential 
mechanism. 
Competitive, uncompetitive, and noncompetitive  product  inhibition 
were fit  to  Equations 2, 3, and 4, respectively. 
Equation 5 describes partially  noncompetitive  inhibition. 
u =  Vm [A  I
K,A (1 + ~ / K I s )  + [AI (1 + ~ / K I I ) / ( ~  + I /KID)  (51 
In  these equations, u is measured velocity, V, is maximal velocity, 
Kd and K,B are Michaelis constants, KIA is an  apparent dissociation 
constant, KIS is a slope inhibition constant, and KII and KID are 
intercept inhibition constants. 
The criteria suggested by Mannervik (1983) and Motulsky and 
Ransnas (1987) were used to determine which models best fit the 
data.  The univariate statistics procedure of the  Statistical Analysis 
System was used to determine the  error  structure of the  data  and  to 
test  the normality of the residual distribution. There was no signifi- 
cant relationship between variance and any  dependent or independent 
variable. Thus equal weight was assigned to each  measurement for 
the fitting process. 
RESULTS 
Physical Properties  and  Substrate Specificity-Hexokinase 
purified  from Artemia  embryos  has a native molecular weight 
of 40,000 * 1,500 (S.E., n = 3) based  on gel exclusion chro- 
matography  with  Sephacryl S-200. This M, is consistent  with 
reported values from  other  invertebrates  (Stetten  and Gold- 
smith, 1981; Moser et al., 1980; Mochizuki and  Hori, 1977). 
The isoelectric point of Artenia hexokinase  was determined 
by chromatofocusing  to be  between pH 4.35 and 4.50, which 
is somewhat lower than PI values reported for yeast and 
mammalian hexokinases (Colowick, 1973; Wilson, 1985). 
Artemia enzyme  displays substantial  catalytic  capacity  with 
Portions of this paper  (including parts of “Experimental  Proce- 
dures”  and “Results,” Table I, and Figs. 1-4) are presented in mini- 
print  at  the end of this paper. The abbreviations used are: DTT, 1,4- 
dithiothreitol; HPLC, high performance liquid chromatography; 
PMSF, phenylmetbylsulfonyl fluoride. Miniprint is easily read with 
the aid of a standard magnifying glass. Full size photocopies are 
included in the microfilm edition of this Journal that is available 
from Waverly Press. 
a variety of sugars  (Table 11), one  characteristic which distin- 
guishes it as a hexokinase rather than a glucokinase. The 
minimal  activity with galactose  suggests that  an axial orien- 
tation of the  C-4 hydroxyl  group may sterically  hinder  phos- 
phorylation at  the  nearby  C-6 position, as suggested by Sols 
and  Crane (1954)  for mammalian  type I  hexokinase. In  con- 
trast, substitution or isomerization at the C-2 position (2- 
deoxy-D-glucose, glucosamine; mannose) does not reduce  ac- 
tivity  as severely. Di-  and  trisaccharides were not good sub- 
strates.  In a separate  experiment, enzyme activity was meas- 
ured in the  presence of 3 mM inosine  triphosphate  and 5 mM 
glucose and was found  to be approximately  10% of the  activity 
with  ATP  as  phosphoryl  donor.  This level of activity with 
ITP is  comparable  to  other hexokinases, but is substantially 
higher than  that observed for mammalian glucokinase (Co- 
lowick, 1973). 
Kinetic Studies with Artemia Hexokinase-The reaction 
mechanism for Artemia hexokinase was studied by examining 
patterns of product inhibition at  pH 8.0 and 6.8. Results 
obtained at   pH 8.0 are shown in Figs. 1-4 (Miniprint)  and  are 
described below. Since  the  patterns of inhibition observed a t  
pH 6.8 were generally similar, these results will only be 
addressed when qualitatively  distinct. 
Plots of l/velocity uersus ]/[ATP],  and  l/velocity uersus 
l/[glucose] at several concentrations of cosubstrate resulted 
in  intersections  in  the s cond quadrant.  These  results  support 
a ternary complex reaction  mechanism for Artemia hexoki- 
nase. There was no  indication of substrate  inhibition by either 
glucose or ATP  up  to  concentrations of 10 and 5 mM, respec- 
tively. 
At saturating  concentrations of cosubstrate,  ADP was 
found  to be an  uncompetitive  inhibitor  toward glucose and a 
partial  noncompetitive  inhibitor  toward  ATP.  In  experiments 
with ATP fixed near its K,, the uncompetitive inhibition 
uersus glucose becomes noncompetitive. When glucose was 
held at subsaturating concentrations, the inhibition versus 
ATP  remained  partial noncompetitive. The  partial  noncom- 
petitive  inhibition  is  characterized by  a  hyperbolic replot of 
intercepts,  and  is described by Equation 5. At all  four  com- 
binations of pH (8.0 and 6.8) and glucose (5 and 0.2 mM), 
fitting  the  data  to  this  equation reduced the residual sums of 
squares  compared to  the fit provided  by the  standard descrip- 
tion of noncompetitive  inhibition  (Equation 4). Inhibition by 
glucose-6-P was somewhat more complex. The  pattern was 
noncompetitive versus glucose at pH 6.8, whereas, inhibition 
at pH 8.0 was  uncompetitive.  At  high  glucose-6-P concentra- 
tions  (24 mM, Fig. 3),  the values depart from those predicted 
by the uncompetitive model, which  suggests a noncompetitive 
TABLE I1 
Sugar specificity of Artemia hexokinase 
Velocity” 
5 m M  sugar 100 m M  sugar 
% % 
Sugar 
Glucose 100 100 
2-Deoxy-D-glucose 91 109 
Mannose 51 I1 
Glucosamine 16 16 
Fructose I 98 
N-Acetylglucosamine 2 21 
Xylose, galactose, arabinoseb 5 1  
a Rate of ADP  formation was measured in the presence of 3 mM 
ATP and 24 mM MgCL (pH 8.0) and expressed as the percent of 
enzyme activity  measured  with glucose. Values for 100 mM sugar were 
determined with partially purified enzyme. 
*Rate of reaction not measured at 100 mM due to confounding 
effects of trace glucose contamination  in  these sugars. 
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TABLE 111 
Product  inhibition of Artemia  hexokinase 
Varied 
substrate Fixed substrate product 
Varied Inhibition pattern" 
DH 8.0 DH 6.8 
Glucose 5 mM ATP  ADP  UCb UCb 
Glucose 0.3 mM ATP  ADP NC ( p  > 0.95)' NC ( p  > 0.995)' 
ATP 5 mM glucose ADP pNC ( p  > 0.999)d pNC ( p  > 0.995Id 
ATP 
Glucose 5 mM ATP Glucose-6-P UCb 
ATP 
0.2 mM glucose ADP pNC ( p  > 0.995)d NC 
5 mM alucose Glucose-6-P Cb C b  
NC ( p  > 0.95)' 
C, competitive;  NC,  noncompetitive; UC, uncompetitive; pNC,  partial noncompetitive  (slope-linear, intercept- 
NC model did  not significantly improve the fit. 
hyperbolic). 
" p  values represent  the probability that  the NC model improved the fit over the UC model. 
d p  values represent  the probability that  the  pNC model improved the  fit over the NC model. 
TABLE IV 
Kinetic  constants of Artemia  hexokinase 
Values are mM f 1 S.E. 
Parameter pH 8.0 pH 6.8 
K,  ATP" 
K, glucose" 0.16 f 0.01 0.12 f 0.01 
0.26 f 0.01 0.29 f 0.02 
K,  glucose" 0.82 f 0.12 
K, ADP 
0.20 f 0.05 
0.86 f 0.09 0.79 f 0.28 
K,  ADPb 
Kd ADPb 
1.0 f 0.3 2.6 f 0.8 
1.9 f 0.7 6.0 f 3.1 
K,, glucose-6-PC 0.065 f 0.005 0.080 f 0.006 
K,, glucose-6-Pd 5.4 f 2.9 
"Parameter values determined by fitting to the equation for a 
sequential  reaction  mechanism (Equation 1). 
Parameter values  determined by fitting  to  the quation  for partial 
noncompetitive  inhibition (Equation 5) at  saturating glucose. 
e Value determined by fitting of competitive inhibition of ATP by 
glucose-6-P at  saturating  concentrations of glucose and glucose-6-P 
< 1.0 mM (Equation 2). 
Value determined by fitting of noncompetitive inhibition of glu- 
cose by glucose-6-P  when ATP is saturating  (Equation 4). 
TABLE V
Intracellular pH and metabolite concentrations  during  active  and 
quiescent metabolic conditions in Artemia  embryos 
Metabolite concentrations are expressed as mM f 1 S.E. ( n  = 
3-6). 
Aerobic Aerobic Anaerobic 
development acidosis dormancy 
pH," 2 7.9 6.8 6.3 
ATP 
ADP 
1.17 f 0.06 1.29 f 0.02 0.34 f 0.01 
0.35 f 0.02 0.37 & 0.02 0.41 f 0.01 
AMP 0.09 f 0.05 0.16 f 0.03 1.16 k 0.20 
Phosphate 12.2 f 0.3 11.4 f 0.1 15.0 f 0.3 
Glucose 0.88 f 0.01 0.99 f 0.03 1.10 f 0.08 
Glucose-6-Pb 0.203 f 0.002 0.051 f 0.003 0.056 f 0.006 
Citrate 0.65 f 0.04  .48 & 0.01 0.46 f 0.04 
a Intracellular  pH measured by 31P NMR  (Busa et al., 1982; Busa 
and Crowe, 1983). 
*Values taken from Carpenter and Hand (1986a) after 4 h of 
aerobic  development, or  after 4  h of aerobic  development followed by 
4 h of aerobic acidosis or 4  h of anaerobic  dormancy. 
component at  very high  levels of inhibitor.  Inhibition versus 
ATP was competitive at  concentrations of glucose-6-P less 
than 1.0 mM, with the inhibition pattern again becoming 
mixed at  higher concentrations. However, this noncompeti- 
tive component was seen only at glucose-6-P concentrations 
5-20-fold greater than in vivo levels. These data suggest that 
glucose-6-P inhibits enzyme activity primarily by operating 
at  the ATP site, and only has low affinity for the glucose 
binding site. The  patterns of product  inhibition observed for 
Artemia hexokinase are summarized in  Table 111. Analysis of 
slope and intercept replots, with their associated 95% confi- 
dence interval, indicated that a  linear model adequately de- 
scribes all data  sets except for the intercept-hyperbolic pat- 
tern of ADP inhibition versus ATP. The kinetic constants 
which resulted from the various fits are found in Table IV. 
Since the K,,, for ATP  and  the Ki for ADP are near the 
cellular concentrations of these two metabolites, perturbation 
of the embryonic adenylate energy charge (Atkinson, 1977) 
would  be expected to influence hexokinase activity. Adenine 
nucleotides were measured in embryos under conditions of 
aerobic development, aerobic acidosis, and anaerobic dor- 
mancy (Table V). Enzyme activity was assayed at  these  aden- 
ylate levels in  the presence of 1 mM glucose and 2 mM MgCL 
and  at applicable pH values. Relative to hexokinase activity 
at  pH 8.0 and energy charge of active embryos (0.83), the 
enzyme activity is reduced by about 62% at conditions found 
in dormant anaerobic embryos (pH 6.3; adenylate energy 
charge, 0.29). Hence, the combination of lowered pH and 
energy charge encountered during anaerobic dormancy can 
account for a significant reduction of hexokinase activity. In 
contrast, enzyme activity under  conditions of aerobic acidosis 
(pH 6.8; adenylate energy charge, 0.81) is only depressed by 
28% relative to  the aerobic value. Because there is a  dramatic 
inhibition of hexokinase in vivo under aerobic acidosis, we 
felt that  there was likely another effector influencing enzyme 
activity at  low pH. 
In addition to glucose-6-P and ADP, several other metab- 
olites were evaluated for potential  inhibitory effects of Ar- 
temia hexokinase activity. Glucose 1,6-diphosphate is claimed 
to be a potent inhibitor of hexokinase at low pH (Beitner, 
1985); but,  at concentrations up  to 500 pM, this compound 
did not alter enzyme activity at  pH 8.0, 6.8, or 6.3 in the 
presence of 1.5 mM ATP and 3 mM MgCL. Fructose, 1,6- 
diphosphate, fructose 2,6-diphosphate, and guanosine diphos- 
phate were also ineffective as inhibitors. 
Aluminum Inhibition-Aluminum dramatically inhibited 
Artemia hexokinase activity at  pH 7.0 but  not at  pH 8.2 (Fig. 
5A). From these data, half-maximal inhibition at  pH 7.0 can 
be estimated to occur at about 0.5 p~ aluminum. Until now, 
this inhibition  has been viewed as  an  artifact of ATP  contam- 
ination and biologically unimportant. However, the  pH de- 
pendence and the severity of the inhibition by aluminum 
prompted us  to investigate the physiological significance of 
the phenomenon in Artemia embryos. 
Total aluminum  in Artemia embryos was measured to be 
4.01 f 0.36 pg/g dry tissue (S.E., n = 11) by graphite  furnace 
atomic absorption  spectrophotometry. Based on  tissue  hydra- 
tion values, the concentration of aluminum  in the embryo is 
approximately 72 p ~ .  Fig. 5B compares the pH profiles of 
hexokinase activity in the presence of 72 p M  aluminum and 
in its absence (i.e. 0.5 mM citrate). At a pH value correspond- 
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FIG. 5. Aluminum inhibition of Artemia hexokinase. A ,  as- 
say conditions were 1 mM glucose, 1 mM ATP,  5 mM MgCI2, and  pH 
8.2 (0) or 7.0 (0). The activity at 0 &M aluminum was measured in 
the presence of 0.5 mM sodium citrate. B,  pH dependence of inhibition 
by aluminum. Control conditions were 1 mM ATP, 1 mM glucose, 2 
mM  MgC12, and 0.5 mM citrate (A). Assays at 72 p M  AICb were 
performed in the absence (0) and presence (0) of physiological metal 
chelators (0.5 mM sodium citrate  and 12.5 mM sodium phosphate). 
Points represent means of two or three determinations of reaction 
rate and expressed as  the percent of the activity a t  pH 8.0. Inset, the 
effect of aluminum concentration on hexokinase activity measured 
at pH 6.8 in the presence of 0.5 mM citrate and 12.5 mM phosphate. 
TABLE VI 
Inhibition of hexokinase  activity  at  near-physiological  levels of p H ,  
metabolites,  aluminum,  and  aluminum  chelators 
Values of pH and metabolite concentrations corresponding to  the 
appropriate metabolic condition were as in Table V, except that 
glucose in all assays was 1.0 mM. Aluminum (as AIC1,) was 72 PM, 
and MgClz  was 2 mM. Enzyme rate was measured as the number of 
micromoles of glucose-6-P formed per min in a 1.0-ml reaction 
mixture over 25 min at 25 "C. Blanks were reaction mixtures with 
deionized water replacing enzyme. Incubations were stopped by the 
addition of perchloric acid to 6%. Following neutralization by potas- 
sium carbonate, glucose-6-P was measured fluorometrically (Lowry 
and Passonneau, 1972). Activity values are means & 1 S.E. ( n  = 3). 
Metabolic  condition Hexokinase Relative 
activity activity 
milliunits/ml % 
Aerobic development (control) 1.59 -C 0.20  10  
Aerobic acidosis 0.19 & 0.03 12 
Anaerobic dormancy 0.14 & 0.06 9 
ing to aerobic development (8.0), aluminum at  this concentra- 
tion  inhibits  the enzyme by 13%. Upon lowering the  pH below 
7.2, 72 pM aluminum depresses enzyme activity by 198%.  It 
is appropriate to note that pH, is 56.8 during quiescent 
metabolic conditions (Busa et al., 1982). This concentration 
of aluminum, which reflects the  total metal content of the 
embryo, is presumably reduced in vivo by complexation of 
AP' by physiological metal ion chelators. Citrate  and  ortho- 
phosphate  are the major small-molecule chelators of alumi- 
num in the cell (Martin, 1986), and  their concentrations were 
also measured in embryos (Table V). When included in assay 
mixtures, both citrate  and phosphate  partially  offset the alu- 
minum inhibition. However, the  pH sensitivity of hexokinase 
activity is still very acute (circles, Fig. 5B).  As shown in  the 
inset to Fig. 5B, this inhibition is observed at pH 6.8 at 
aluminum concentrations as low as 10 pM. 
In a final experiment, we measured hexokinase activity 
with the discontinuous assay described in Table VI, which 
permits including both ADP and glucose-6-P simultaneously. 
The physiological levels of pH, chelators, and metabolites 
that were used are given in  Table V. MgClz  was present at  3 
mM and AlCl, at  72 p ~ .  When compared to  the activity under 
conditions  simulating aerobic development, hexokinase is in- 
hibited by 88% under aerobic acidosis and 91% under anaer- 
obic dormancy (Table VI). 
Binding Experiments-Hexokinase activity in crude ex- 
tracts of Artemia embryos is predominantly in the soluble 
fraction following centrifugation at  20,000 X g. Incubation of 
1000 X g pellets and supernatants with 1 mM glucose-6-P 
(known to elute  type  I hexokinase from mitochondria; Chou 
and Wilson, 1972) did not increase hexokinase activity in the 
20,000 X g supernatant.  In experiments utilizing sucrose ho- 
mogenization, the soluble hexokinase still accounted for 
290% of the  total enzyme activity. This figure does not change 
as a function of the metabolic state of the embryos (aerobic 
development or anaerobic dormancy). Experiments with pu- 
rified enzyme failed to indicate  any  interaction of the enzyme 
with isolated mitochondria or yolk platelets. Thus, we have 
no evidence at  present that regulation of Artemia hexokinase 
activity is dependent on reversible binding to intracellular 
structures. 
DISCUSSION 
The primary focus of this study was to examine the catalytic 
and physical properties of hexokinase from Artemia embryos 
in order to identify the molecular characteristics responsible 
for the reduction in flux at this step in glycolysis during 
metabolic arrest in the species (Carpenter and Hand, 1986a). 
Product inhibition, reaction mechanism, subcellular distri- 
bution, and aluminum  inhibition are interpreted  in the con- 
text of metabolic control  in Artemia embryos, and related to 
hexokinases from other sources. The results have implications 
for the evolution of hexokinase homologues. 
Reaction Mechanism of Artemia Hexokinase-The patterns 
of product inhibition observed in the present  study are not 
characteristic of typical ordered or random bireactant mech- 
anisms. However, when all the  data  are considered, they are 
consistent with a  random mechanism with the preferred order 
of glucose binding first and glucose-6-P dissociating last.  A 
preference for this route of substrate addition and product 
release has been reported for hexokinases from yeast (Danen- 
berg and Cleland, 1975) and mammals (Ganson and Fromm, 
19851, although the  extent  to which the mechanism is random 
is currently  debated (Gregoriou et al., 1986; Bass and Fromm, 
1987). We feel that  in Artemia hexokinase, the pathway is 
effectively ordered at  physiological concentrations of sub- 
strates  and products, but  the random mechanism is required 
to explain some of the inhibition patterns  at high levels of 
products. It is appropriate to note that the equations of 
Rudolph and Fromm (1971) for a  rapid equilibrium random 
mechanism do not apply to Artemia enzyme. Scheme I  sum- 
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A'P CLC G6" ADP 
r -  < j & E z < - . - z  ' A  
G6p t ADP 
I':GLC.GW) FIGLC ADP) 
SCHEME I. GLC, glucose; G6P, glucose 6-phosphate. 
marizes  our interpretation of product  inhibition  studies with 
Artemia  hexokinase. 
Support for the ordered nature of the mechanism is found 
in  the  pattern of inhibition by  ADP. In  the proposed mecha- 
nism, ADP is usually the  first  product released and,  as such, 
is expected to be a noncompetitive inhibitor when either 
substrate  is  held  at  unsaturated  concentrations. At saturating 
concentrations of first  substrate (glucose), the  predicted  pat- 
tern of inhibition versus the  second  substrate  (ATP)  remains 
noncompetitive. In  contrast, when the second substrate 
(ATP) is held a t  saturating concentrations, the pattern of 
inhibition uersus the  first  substrate (glucose) should  change 
to uncompetitive. Our  data fulfill these predictions. 
The slope-linear, intercept-hyperbolic noncompetitive in- 
hibition of ADP uersus ATP  has been previously documented 
for yeast hexokinase (Kosow and Rose, 1970; Viola et al., 
1982). The  explanation offered by Kosow and Rose (1970) for 
this  pattern recognizes two sites of ADP  inhibition,  an effect 
on  product release and a competitive interaction versus ATP 
at  the active  site. As inhibitor  and  substrate  concentrations 
are increased, the  interaction becomes predominantly com- 
petitive, giving a hyperbolic  replot of intercepts.  The obser- 
vation of competitive inhibition of ADP  toward  ATP suggests 
that  the mechanism is partly  random at high concentrations 
of substrate  and  product (Viola et al., 1982). Scheme I includes 
the  formation of an enzyme-glucose-ADP dead-end complex 
to account for the competitive portion of the hyperbolic 
inhibition. 
Competitive inhibition of glucose-6-P versus ATP is not 
predicted in a typical random  mechanism,  but  can be resolved 
by the  formation of the  dead-end complex enzyme-glucose- 
glucose-6-P (Scheme I). In a random  mechanism, a  competi- 
tive  inhibitor of ATP would be  expected to be  noncompetitive 
versus glucose (Fromm, 1983), and  this  pattern  is observed in 
a variety of hexokinases (Purich et al., 1973). Fitting our 
glucose-6-P versus glucose data to a noncompetitive model 
reduced the residual sums of squares relative to  the  uncom- 
petitive model at both  pH 8.0 and 6.8. The  improvement  in 
the fit was not significant at  pH 8.0. Thus,  the  simpler model 
(uncompetitive) was accepted as suggested by Mannervik 
(1983). This uncompetitive inhibition  supports  the proposal 
that  there is a  preferred route of substrate  addition for Ar- 
temia  hexokinase,  since  a  competitive inhibitor of the second 
substrate  in  an ordered  mechanism would be uncompetitive 
versus the first substrate (Fromm, 1983). At the lower pH, 
the  switch  to noncompetitive inhibition may reflect either  an 
increased flux through  the  alternative  route of substrate  ad- 
dition or a  secondary interaction of glucose-6-P at the glucose 
site. 
Considerable debate  exists  about  the  nature of glucose-6-P 
inhibition of mammalian hexokinases. Fromm  and colleagues 
(Bass and Fromm, 1987) hold that inhibition results from 
competition between glucose-6-P and  ATP for the y-phos- 
phate  subsite of the active site, while  Cornish-Bowden and 
others (Gregoriou et al., 1986)  favor  allosteric modification by 
glucose-6-P. The latter position is supported by structural 
studies  that  present evidence for gene duplication-fusion  in 
the evolution of mammalian hexokinases (White  and Wilson, 
1987; Schwab and Wilson, 1988). Briefly, the  argument holds 
that  the  ancestral hexokinase was of the  order of 50,000 Da; 
and  duplication of the gene coding  for this  protein, followed 
by fusion of the gene copies, has resulted in a 100,000-Da 
molecule. One active site remained catalytically competent, 
while an allosteric site  arose from  modification of the  alter- 
native active site. While this may be the case  in mammalian 
isozymes, it cannot adequately explain the acute inhibition 
by glucose-6-P of Artemia enzyme,  which has a native molec- 
ular weight of 40,000. Consequently, we feel that  the  inhibi- 
tion by glucose-6-P is a result of competition with ATP  at   the 
active site. 
Absence of Hexokinase Interaction with Mitochondria-An- 
other  feature of the enzyme  which can be rationalized in  light 
of structural differences between mammalian and Artemia 
hexokinases is  the capacity to  bind  to mitochondria. Mam- 
malian  brain hexokinase  possesses three  discrete domains: an 
N-terminal10,OOO-Da polypeptide; a middle domain of 50,000 
Da;  and a 40,000-Da C-terminal  segment  (White  and Wilson, 
1987). The  N-terminal polypeptide mediates binding  to mi- 
tochondria, whereas the  catalytic  site resides within  the C- 
terminal portion (White and Wilson, 1987). The Artemia 
enzyme is expected to be  homologous to  the  mammalian C- 
terminal region, thus  lacking  the  peptide responsible  for re- 
versible mitochondrial binding. 
Influence of Substrates  and Metabolites under in Vivo Con- 
ditions-The importance of the individual kinetic  constants 
and pH-related alterations thereof in determining enzyme 
rate  in vivo can  only be assessed in  context of cellular metab- 
olite  concentrations. Using an  equation  for a sequential  mech- 
anism  that  incorporates competitive inhibition by glucose-6- 
P (Segel, 1975) and kinetic constants from Table IV (and 
including  a 20% reduction in V,  at  pH 6.8 relative to  pH 8.0), 
we calculated hexokinase activity a t  physiological substrate 
and  product  concentrations  (Table V). The calculated rate of 
hexokinase  under  anaerobic  conditions, applying the  pH 6.8 
kinetic  parameters,  is 32% lower than  the value calculated  for 
aerobic  conditions. Hence, while the decrease in glucose-6-P 
predicts  an  activation relative to aerobic conditions, a marked 
decline in  ATP  concentration  results in moderate  inhibition 
of the enzyme. During  the  transition from aerobic develop- 
ment  to aerobic  acidosis, however, ATP levels to  not  change 
while glucose-6-P  declines, and  the  predicted velocity under 
these  conditions  represents  an  activation of 20% above aero- 
bic conditions.  Because the  ADP  concentration is relatively 
stable under these treatments, inhibition by this product 
should be similar  in all three cases. Thus,  product  inhibition 
alone  cannot explain the negative  cross-over  observed at the 
hexokinase reaction during  aerobic acidosis (Carpenter  and 
Hand, 1986a), and we felt  that  another effector is likely to be 
inhibiting enzyme activity at  low pH values. 
Aluminum Inhibition: Possible Significance for Metabolic 
Arrest-Aluminum ion, which has been demonstrated  to be a 
powerful inhibitor of yeast  and  mammalian hexokinases, is 
likewise a potent  effector of Artemia  hexokinase at low pH. 
This inhibition is presumably due to the formation of Al- 
ATP- which competes with Mg-ATP2- for the nucleotide 
binding  site  (Womack  and Colowick, 1979; Neet  et al., 1982). 
Because 50% maximum inhibition occurs at about 0.5 FM 
aluminum (Fig. 5A)  and  the K ,  for  Mg-ATP2-  is 290 pM, the 
AI-ATP- appears  to  bind  approximately 3 orders of magnitude 
tighter to  the enzyme than does the substrate. Neet et d. 
(1982) proposed that AI-ATP- binds  to  the enzyme-glucose 
complex, inducing a slow conformational  change  to  an  enzyme 
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form which is  not catalytically competent.  While only steady 
state velocities are  reported for Artemia hexokinase, the ob- 
servation  that  citrate  activation of the  inhibited enzyme re- 
quired 1-2 min prior  to  establishment of a linear  rate  supports 
this suggestion.  Although inhibition by aluminum  is severe at  
pH values below neutrality,  the effect is not observed  above 
pH 8.0. There  are a number of explanations for this lack of 
inhibition at  higher pH values. The effect of increasing solu- 
tion  pH  on mononuclear aluminum species causes  the free 
AP+ concentration  to  drop  dramatically  as  pH rises (Martin, 
1986). High  pH values foster the formation of polynuclear 
aluminum species (Akitt et al., 1972), which may  be too large 
to complex  with ATP.  Finally AI-ATP- has a pK value of 7.6 
and is much  less effective as a competitor of Mg-ATP2- above 
this  pH (Viola et al., 1980). 
To  our knowledge prior studies have not experimentally 
addressed  aluminum  inhibition of hexokinase at in  vivo values 
of pH and metal ion chelators. At pH values, metabolite, 
aluminum,  and  chelator  concentrations  corresponding to an- 
aerobic dormancy  and  aerobic acidosis, hexokinase  activity in 
vitro was inhibited by approximately 90% compared to  the 
activity under conditions which stimulate aerobic develop- 
ment.  Our  measurements of enzyme activity were performed 
a t  72 I.LM aluminum, which assumes that the total tissue 
aluminum  exists in  soluble form. We recognize that  aluminum 
can  form complexes  with  a variety of small molecules as well 
as some proteins,  and  thus we included in  our  assays  its major 
cellular chelators  (citrate  and  phosphate)  at  concentrations 
that reflect total  tissue  content? Aluminum inhibition could 
also  have  implications for Alzheimer’s disease (Crapper et al., 
1976), dialysis encephalopathy  syndrome (Alfrey et al., 1976), 
and Parkinsonism (Garruto et al., 1984), all of which are 
correlated with elevated aluminum concentrations in brain 
tissue. In  this  context,  Lai  and  Blass (1984)  documented that 
micromolar amounts of aluminum  inhibit glycolysis in  mam- 
malian  brain  extracts. 
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Supplemental  Matertal to 
tilnerlc  propemes of hexokinase  under near-phyrdogical  condittanr: 
Relation to metabolic  arrest ~n Arremta embryos durmg anoxia 
Bernard R .  Reer. Ira 1. Ropson,  and Steven C. H h d  
EXPERIMENTAL  PROCEDURES 
Moicrrols. DEAE-cellulose. Sephacryl S-200, Palybuffer 74. Polybuffer exchanger 94, 
dehydrogenase (rabbit mucic. type 11). NADP  and NADH  were  purchased  from  Sigma 
glucose-6-P  dehydrogenaae  (yeast,  type VU), pyruvate  kinase  (rabbit muscle. type  Ill, lactate 
Chemlcal Company. All other chemicals were reagent grade Ruffers and reagents were 
madc  wtth  water  dewxized by a  Mill>- Q reagent  water  system  (Conllnenral Waxer Systems. 
Inc 1. Encysted Anemm embryos from the Great Salt Lake were purchased from Sanders 
Brlne Shnmp.  Co..  Odgen. Utah and  stored at -2OOC. 
Ln:,vmc Purrficmon Unless otherwtse specafied. all steps were performed at 0-4oC. 
volumeb of hamogenzation medlum (50 mM TrisIHCI  buffer. pH 8 0, contaming 2 mM Dm. 
After lhorough  waahtng  and hydration (Hand et al.. 1981).  cysts  were  homogenized In 3 
0. I mM  PMSF  and I pglml soybean  trypsin  mhlbror)  wtth a V m s  " 4 s  homogenirer. The 
inmumem was fitted with a Macro Ultra Shear  adaptor  and  operated at full speed in 4  I-min 
bunt, The homogenate was filtered through glass wool and centrifuged at 1000% for 10 mln 
at 20.000g for 30 mm 
to remove ruptured cyst walls and cellular d e b r i  The rerultmg supematant  wa\  cenlnfuged 
prcclpttatmg  between 40 and 60%  saturat~on was collected  by centnfugatwn at 15,ooOg for IS 
The  enzyme  supematant was fractionated with solld  (NHqjzS04. and the  protem 
mm R e  pellet was resuspended in 50 mM  Na-phosphate  buffer.  pH 7.0, with 1 mM DTT 
and 0 I mM  PMSF  (DEAE  buffer), dlalyzed  ovemlght,  and  clarified by centrifugation at 
added  balchwne to the  hexokinase  preparatlan (30 g hydrated resinll0O ml enzyme  solution) 
I5.000g for 15 mm. Washed  DEAE-cellulose resin was equihbrated with DEAE  buffer  and 
After lncubating for I h on KC, the  restn-enzyme slurry was poured into a 2.5 x 20 cm 
column and  washed  sequentially  wlth  DEAE  buffer  and  DEAE  buffer  contaming 100 mM 
tiCI (I 0 mllmm flow rate).  Hexokmase was subsequently  eluted wtth 300 mM KC1 in DEAE 
buffer.  The  enzyme  was concentratcd by (NH&S04  precipitation. redissolved In a mmmal 
volume of gel ftltratlon buffer  (50  mM  TrtsIHCI.  pH 7.5. I o 0  mM glucose. I mM DTT. I 
mM EDTA, 0.1 mM  PMSF  and 100 mM  KCI),  and  dlalyzed  overnight.  Ahquats of 2.2 ml 
were chromatographed on a Sephacryl  S-200 column (1 .5  x X0 cm) at a flow rate of 5.0 mlin 
Hexokinare  activity was pooled lrnm all runs. For estmatmn of molecular weight, thn gel 
f l l t ratm column was caltbrated wlth the following reference proteins: thyroglobulin. 
669.000 ( for   de tennat ion  of exclusion volume). catalase, 232,000. aldolase. 158,ooO, 
transferrin, 74.000; ovalbumin. 41.000. 
R e  final  purificatm  step was chromatofocusing on Polybuffer  exchanger 94 (1.0 x 20 
cn, column: 23 ml/h flow rate) The staning buffer war 25 mM  histidinemaOH.  pH  6 0. and 
thc elutmn buffer  was  a 1 9 dilution of Polybuffer 74 adjusted to pH 4.0 w ~ t h  HCI. Glucose 
(50 mM) was included in both  buffers to help  preserve  hexokinase  activity at low pH. The 
enryme was dlalyzed  extensively agalnct the atanmg buffer  before applicauon. Hexokmase 
rctlvity  eluted  between pH 4.6 and 4.2, and the enzyme was Immediately  titrated to neutrality 
with NaOH and  dialyzed against stabilmtion buffer (35 mM TrnlHCI. pH 8.0. 2 mM DIT.  50 
mM glucose). Throughout  the  puriftcatmn,  pratem was measured by the method of Lowry et 
81. (1951) as modified by Peterson  (1977) 
the mr rmg  enzyme  units  (Table I ) .  Enzyme purity was 94% as determined by 
electrophoresx on "on-denaturing gels of 7% acrylamide (Davis, 1964). Gels were stamed 
for total pratem  with  fast green dye  (Gorovsky et al , 1976) and  densltometncally  scanned at 
630 nm 
This scheme  resulted  in a 1200-fold ennchmenent of hexokmase  and gave a 9% recovery  of 
TABLE I: Purification of hexakmase  from Arremta embryos 
Step Activlty 
(unitsP 
Spealic Activity 
(unmlmg protein) 
20,000g  Supematant 
Ammanwm Sulfate 
DF.AE-cellulose 
Sephacryl S - 2 0 0  
Chronmofocuatng 37 88 
4% 
216 
I 46 
98 
0.0R 
0.14 
0.75 
I . I  
~ 
nActwty measured as rate of glucose-6-P  production ~n the  preqence of 5 mM  glucose, 3 mM 
ATP  and 6 mM MgCI2 (pH 8.0) 
Heroktnose Asroys. Henokmaw actwiry wab measured  spectrophotametrically (340 nrn) 
glucox-6-P  dehydrogenase) or ADP (1.5 mM phosphoenolpyruvate, 10 mM KCI, 0 2  mM 
at 25oC by following the  productmn of etther  glucose-6-P (0.5 mM NADP, 0 5-1 0 unillml 
buffer (50 mM  each) Both enzyme couples resulted in Identical reactmn rates The assay pll 
NADII. 30 umtslml each of pyruvate  kinase  and  lactate  dehydrogenase) ~n Tns-imidazole 
and  concentrations of glucose. ATP,  ADP and glucose-6-P  were vaned as specified 5" the 
results, and MgC12 was adjusted m each reactmn mtxture h o  that  the  concentrauon of free 
Mg?+ WBF between I and 3 mM.  For d ~ e  purpose o f  calculating MgCl2 levels.  the stability 
conrtants of 20.wO. 4000 and 100 were  adopted  for MgATP2.. MgADP- (OSulllvan and 
P m m .  1964) and MgAMP (Smlth and Albeny, 1956). respectlvely. Accessory enzynler were 
dlalyzed  agamst  assay  buffer to remove (NH4)2S04.  One unit of hexokmase  acllvlty I \  
dcfmed as the amount catalyzing  the  phosphorylation  of I pmol of glucore per minute. 
IO be 88.9 f 2.5 ppm (SEM. n = 3). whlch  corresponds to a molar ratio  of 1:500 (AI ATP) 
Attempts to remove the  endogenous  aluminum  by ion exchange  chromatography  (Chelex 1 0 0 )  
reduced the ton by 30-7090.  comparable  with the results o f  Neet et a1 (1982).  Recawe 
complele removal  was no1 possible  with  lhis  method.  we  instead  mrluded 0.5 mM sododlum 
c~tratc  In assay  buffers to chelate  aluminum. To substantiate that citrate  activatmn at low pl l  
YBIUCS wa5 excluswely a rewit of alummum  chelation,  data  obtained at pH 7.0 and preqented 
in R g  5A were graphed as a Dixon plot (Segel, 1975). The extrapolated Intercept at 0 pM 
Al3f was wlthin 1% of value  obtained in the  presence of 0.5 mM cltrate. In experlmenrr 
alummum  (as AICI?), ATP, MgC12 were preincubated  wlth or without chelatar(a) m 
~nvestlgating alummum mhibirmn. citrate was included Only as indicated In these studies. 
concentrated  solutions on ice for 1-4 hr  prior to initiauon of enzyme  assays. 
We  measured  aluminum m Sigma disodium  ATP from equine muscle (Lot # SSP-7095) 
Binding Srudrcs. The subcellular  distribution of hexokmase  was  evaluated  in 
metabdlcally  actwe  and quiescent embryos.  Followmg  incubation of embryos under 
candttions of aerobic  development or  anaerobic  dormancy  (Carpenter  and  Hand.  1986a). 
tripllcate  samples of embryos  were  homogenized In 800 mM sucrose. 1 mM DIT. 0.1 mM 
PMSF  and  centrifuged at 20.000g for 10 min, a procedure  which IS known to preseve 
enzyme-organelle assmation m mammalian skeletal musclc  (Clarke el al.. 1984)  and  selected 
mvertebrate ttssues (Plarton and Storey,  1986). The supernatants  were  combined  with 3 
volumes of rolub$lrralion  buffer (100 mM K-phosphate.  pH 7.5.200 mM KCI, I mM  DTT. 
0. I mM  PMSF)  and  assayed for hexokmase actwty.  The pellets  were  washed t w ~ e  in 
solubilizatm buffer to liberate  any b u n d  enzyme. 
assessed following the  protocol of Adams et al. (1988). The potential  interaclmn of 
hexokinase  and Arremio yolk  platelets was also investigated. Yolk platelets  were  purified as 
Utterback  and Hand (1987) and  incubated at a conccntntion of 10R/mI for 20 min  with 
enriched  enzyme  at  either  pH 8.0 or 6.3 ( S h M  Tris, SO mM citrate  buffer  with  ImM 
and  pellet  fracoans. 
MgC12) Following centrifugation (700g). hexokinase actiwty was measured tn supematant 
Rmding of purified  hexokmase to isolated  embryo  mttochondria  (13 mdml protein) was 
Mearuremenr of merobolires and aluminum. Perchloric  amd extracts of freeze-clamped 
embryos were prepared as in  Carpenter and Hand (1986a). Adenine  nucleotides  were 
measured  with  high performance liqutd  chromatography  using a procedure  modified  from 
X  25 cm: 5 p n  particle stre) fmm Jones Chromatography  and  eluted  isocratically  wlth 0 1 M 
Sehweinsberg  and L w  (1980).  Nucleotides  were  separated on an  Octadecyl column (4.6 mm 
potassium  phosphate  buffer. pH 6.0. T h i s  HPLC method is supenor to enzymatically-coupled 
fluorometric  analyses of ADP because  it  avoids interference by GDP. Citrate  content was 
determined  fluorometrically following the  method of Lowry and Passonneau  (1972).  The I 
0.016-0.064 unit c~trale lyase m 100 mM TrisRICl  buffer  (pH 7.6). Inorganic  phosphate was 
ml reaction mixlure contained 10 pM  NADH, 8 p M  ZnSO4. 1 unit malate dehydrogenase and 
determmed  spectrophotomevically  as  descnbed by Piper and Love11 (1981).  except that 7 5% 
rather  than 2.5% ammonium molybdate  was mluded  in the  reagent. 
Aluminum  was  measured in ATP stocks and Arremia embryos  fallowing  a  procedure 
madlfied from Crapper  et al. (1976).  Hydrated  embryos  were  treated with an antiformm 
completely remove the chorion,  followed by extensive nnsing with demnired HtO. 
solullon (0.4  M  NaOH, 60 mM NaZCOZ. 2.5% active  hypochlorite)  for 30 min on ~ c e  to
Approximately 100 mg of embryos  were  transfemd to q u a m  crucibles. dned at 7WC to 
Constant dry  weight. and ashed at 55WC  for 20 h. The ash was resuspended ~n 100 pI 5% 
HNO?  and  brought to 1.0 ml with  demnized H20. Particulate  material  which  did not dissolve 
was removed by centrifugation at 1O.ooOg for IO min. AI,+ was measured m the  supematant 
wlth a  Varlan  Graphite  Furnace  Atomlc  Absorption  Spectrophotometer. 
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IHGURE 1 Double recrprocal plots of velocity (102 unm) versus glucose concentratwn 
fixed at 5 mM ADP  cnncenlratlms: 0 mM (0): 0.5 mM (0) 2.0 mM iAJ. 4.0 mM (\j
i m M j  at varied concentrationr of ADP. Avays were  performed at pH 8 0. and ATP was 
are predicted by no"-linear regresstan using the uncompetmve  model oi inhibmon 
and 8.0 mM (a). Points  %present means of 2-4 determmations of enzyrnkacrivily. I.& 
(goodness of fit,  r2 = 0.991). 
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FIGURE 4: Double  reclpmcal  plots of velocity ( IO2  unltsj versus ATP  concentration (mM) 
at varied concentrations of glrcose-6-P.  Assays were performed at pH 8.0 and glucose 
was fixed at 5 mM Glucose-6-P concentratma were: 0 mM (0). 0.1 mM (0) 0.4 mM 
( 4  and I .O mM ( a )  Points  represent  means of 2-4 detemmatibns of enzynie  acrivlty. 
Lines  are predicted by non-linear  regression uslng the competrtive model of mhlhition f i t  
lo glucose-6-P  concentrattons 4 mM ir2 = 0 985. see  Results) 
FIGURE 2. Double reciprocal plots a i  velocity (IO2 units) versus ATP concentration 
(mM) at  vaned concentrations of ADP.  Assays  were  performed at pH 8.0, and glucose 
was fixed at 5 m M  ADP  wncentrattons ware as in Figure I .  Points represent means of 
2-4 determinations of enzyme  activity. L m s  are predicted  by non-hea r  regression usmg 
the slope-linear.  intercept-hyperbolic  noncompelitlve  model of inhlbrtion ( r2 = 0.984). 
